The mTOR signaling pathway’s oncogenic activation contributes to the growth, proliferation, and survival of cancer cells, emphasizing the potential of mTOR pathway inhibitors to serve as efficient anti-cancer drugs (9, 10). Here, MTOR is linked to cancer.